Bristol-Myers Squibb Company(BMY)

Sector:

Healthcare

Description:

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple myeloma; Eliquis, an oral inhibitor for reduction in risk of stroke/systemic embolism in NVAF, and for the treatment of DVT/PE; Opdivo for anti-cancer indications; Pomalyst/Imnovid indicated for patients with multiple myeloma; and Orencia for adult patients with active RA and psoriatic arthritis. It also provides Sprycel for the treatment of Philadelphia chromosome-positive chronic myeloid leukemia; Yervoy for the treatment of patients with unresectable or metastatic melanoma; Abraxane, a protein-bound chemotherapy product; Reblozyl for the treatment of anemia in adult patients with beta thalassemia; and Empliciti for the treatment of multiple myeloma. In addition, the company offers Zeposia to treat relapsing forms of multiple sclerosis; Breyanzi, a CD19-directed genetically modified autologous T cell immunotherapy for the treatment of adult patients with relapsed or refractory large B-cell lymphoma; Inrebic, an oral kinase inhibitor indicated for the treatment of adult patients with myelofibrosis; and Onureg for the treatment of adult patients with AML. It sells products to wholesalers, distributors, pharmacies, retailers, hospitals, clinics, and government agencies. The company was formerly known as Bristol-Myers Company. The company was founded in 1887 and is headquartered in New York, New York.

Current Price

$65.66

RSI

60.45

Market Capitalization:

162.5B

Beta:

0.536

Volume:

6,768,783

Analyst Target Price:

$ 78.5

Economiic Fair Price:


February 02, 2023
October 26, 2022
Q3
3.43 %
$ 1.96
2.88 %
$ 2.01
22.40 %
7.7B
39.1B
3.12
13.30 %
21.36
0.19

2.89 %
28.24 %
-13.39 %
-3.49 %
2.41 %
-31.14 %

$ 46.4B
9.09 %
$ 42.5B
62.62 %
$ 26.1B
15.89 %
$ 22.6B
8.59 %
$ 20.8B
6.94 %
$ 19.4B

$ 15.2B
14.55 %
$ 13.3B
83.92 %
$ 7.2B
44.94 %
$ 5B
18.22 %
$ 4.2B
158.10 %
$ 1.6B

$ 8.1B
217.86 %
$ -6.9B
-238.11 %
$ 5B
-16.64 %
$ 6B
16.31 %
$ 5.1B
-13.25 %
$ 5.9B

News

Press Releases

Notable Dates